Pharmacy Claims Data
Buy and sell pharmacy claims data data. Adjudicated claims with plan details, copays, rejections — PBM analytics AI needs real claims flow data.
No listings currently in the marketplace for Pharmacy Claims Data.
Find Me This Data →Overview
What Is Pharmacy Claims Data?
Pharmacy claims data comprises adjudicated insurance claims for prescription medications, including National Drug Code (NDC), therapeutic class, pill quantity, treatment days, dispensing date, payer type (commercial, Medicare Part D, Medicare Advantage), out-of-pocket costs, third-party expenditures, and pharmacy location. This data captures the complete claims flow from dispensing through payer adjudication, including copays, rejections, and plan details. Life sciences companies and PBMs use pharmacy claims data as a foundational real-world evidence source to track treatment utilization, optimize formularies, and support drug development and commercialization strategies.
Market Data
USD 3.51 Billion
U.S. Retail Pharmacy De-identified Health Data Market Size (2025)
Source: Nova One Advisor
USD 6.95 Billion
Market Forecast by 2034
Source: Nova One Advisor
CAGR of 7.89%
Projected Growth Rate (2025–2034)
Source: Nova One Advisor
CAGR of 15.9%
Real-World Evidence Solutions Market Growth (2025–2026)
Source: Research and Markets
Who Uses This Data
What AI models do with it.do with it.
Pharmaceutical Market Access & Drug Development
Pharma companies leverage pharmacy claims data to track prescription patterns, optimize formulary positioning, and support regulatory submissions with real-world treatment evidence during drug development and post-approval monitoring.
PBM Analytics & Utilization Management
PBMs use claims data to analyze drug utilization patterns, manage prior authorization workflows, evaluate formulary performance, and optimize plan design and rebate negotiations with manufacturers.
Health Plans & Payers
Employers and insurance plans analyze claims data to assess PBM performance, negotiate rebates, understand treatment costs, and identify opportunities for cost containment and clinical optimization across their membership.
Clinical Research & Real-World Evidence
Life sciences researchers combine pharmacy claims with EHR data to understand patient populations, treatment outcomes, comorbidities, and diagnostic patterns to inform clinical trial design and patient recruitment strategies.
What Can You Earn?
What it's worth.worth.
Research Reports & Market Intelligence
€4,034–USD 4,490
Single-use research reports covering pharmacy claims data market analysis and trends
Data Licensing & Analytics Platforms
Varies
Customized data access and analytics depend on data volume, granularity (patient-level vs. aggregated), de-identification requirements, and use case (clinical research, commercial intelligence, formulary optimization)
PBM & Payer Audits
$15,000–$200,000
Employers audit PBM performance by purchasing itemized claims data and rebate disclosures to benchmark PBM accountability and negotiate better terms
What Buyers Expect
What makes it valuable.valuable.
Complete Claims Documentation
Adjudicated claims must include NDC code, therapeutic class, pill quantity, treatment days, dispensing date, payer identification, plan type, and both patient out-of-pocket and payer costs.
De-identification & HIPAA Compliance
Data must be de-identified per HIPAA standards to protect patient privacy while maintaining analytical value for research, formulary analysis, and treatment pattern tracking.
Payer & Rejection Detail
Buyers require clarity on plan details, copay structures, claim rejections, and prior authorization outcomes to understand coverage policies and optimize reimbursement workflows.
Demographic & Enrollment Context
Data should include patient demographics (age, sex), plan type (commercial, Medicare Part D, Medicare Advantage, Medicaid), and pharmacy location to enable population health and market access analytics.
Companies Active Here
Who's buying.buying.
Health plan operators and PBMs analyzing claims data for formulary optimization, rebate negotiations, prior authorization analytics, and utilization management.
Life sciences and real-world evidence platforms acquiring pharmacy claims data to support drug development, clinical trials, and post-approval evidence generation.
Retail pharmacy chains monetizing de-identified claims data from their dispensing networks to pharmaceutical, payer, and research organizations.
Data analytics and enterprise software firms enabling aggregation, analytics, and insights from pharmacy claims for pharmaceutical, payer, and health system clients.
Health data networks and intermediaries aggregating pharmacy claims from multiple sources to serve pharma, payers, and research communities.
FAQ
Common questions.questions.
What specific data elements are included in pharmacy claims?
Pharmacy claims include National Drug Code (NDC), therapeutic class, pill quantity, number of treatment days, dispensing date, payer type (commercial, Medicare Part D, Medicare Advantage, Medicaid), out-of-pocket and third-party payer expenditures, pharmacy location, and patient demographics such as date of birth and sex.
How do pharma companies use pharmacy claims data?
Pharmaceutical companies use pharmacy claims to track real-world prescription patterns, understand treatment utilization across patient populations, optimize formulary positioning, support post-approval safety monitoring, and generate real-world evidence for regulatory submissions and market access negotiations.
What is the difference between pharmacy claims data and EHR data?
Pharmacy claims data captures what was dispensed, when, how much it cost, and payer details, but lacks clinical outcomes and diagnostic information. EHR data includes medical history, symptoms, comorbidities, and treatment outcomes, but may not have complete claims and pricing detail. Combined, they provide richer insights for clinical research and patient population analysis.
Why do employers audit PBM pharmacy claims data?
Employers audit claims data to verify PBM performance, understand rebate amounts, compare costs across alternative PBMs, and identify spread pricing or formulary exclusions that may inflate drug costs. Audits typically cost $15,000–$200,000 and provide itemized claims transparency otherwise unavailable.
Sell yourpharmacy claimsdata.
If your company generates pharmacy claims data, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation